Search Results - "Rico, G. Tapia"

The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence by Tapia Rico, G., Chan, M.M., Loo, K.F.

“…•Immunotherapy has revolutionized the treatment paradigm in many cancers.•Patients with chronic viral infections are generally excluded from oncology…”
Get full text

A systematic review of immune checkpoint inhibitor-related neurological adverse events and association with anti-neuronal autoantibodies by Salim, Ayesha, Tapia Rico, G, Shaikh, A, Brown, M P

“…: Immune checkpoint inhibitors (ICI) therapy has led to a paradigm shift in cancer drug development and in the clinical evaluation of approaches to combination…”
Get more information

2157P A phase II randomised controlled trial comparing the cardiotoxicity of capecitabine and S-1 by Clive, S., Bularga, A., Henriksen, P., Newby, D.E., Wall, L.R., Dawson, L., Brown, E.R., Evans, E., Denham, S., Homer, N., Demyanov, O., Muir, S., Tapia-Rico, G., Peel, N., Christie, A.

Get full text

Brain metastasis in advanced colorectal cancer: Results from the South Australian metastatic colorectal cancer (SAmCRC) registry by Price, T.J., Karapetis, C., Piantadosi, C., Rico, G. Tapia, Padbury, R., Maddern, G., Moore, J., Carruthers, S., Roder, D., Townsend, A.R.

Get full text

MVAC vs Platinum – Gemcitabine (PG) in a Risk-Adapted Policy of Adjuvant Chemotherapy (ACT) after Radical Cystectomy (C) in Patients with Invasive Bladder Carcinoma (IBC) by Arija, J.A. Arranz, Solis, R. Mondejar, Martí, M.P. López, Domínguez, P. Sabin, Lopez, M.C. Lopez, Rico, G. Tapia, Ortega, B. Moya, Velasco, D. Urosa, Juarez, E. López, Beca, R. González

Get full text